- Successful preclinical proof-of-concept study of a CAR-T cell approach targeting CD84 to treat acute myeloid leukemia. Hum Gene Ther 2025;36:e165.
- Preclinical development of a CAR-T cell approach targeting the CD84 antigen associated to pediatric acute myeloid leukemia. Blood 2022;140(Suppl 1):10247-10248.
- CD72 is a pan-tumor antigen associated with childhood acute leukemia. Blood 2022;140(Suppl 1):4974-4975.
